Summary
Thermo Fisher Scientific Inc. (TMO) filed an 8-K on December 18, 2009, reporting on two significant debt management actions. The company announced the successful settlement of its redemption for all outstanding 6.75% Senior Subordinated Notes due 2014, totaling approximately $317.0 million. This action effectively retired a significant portion of its long-term debt. Furthermore, the company reported the expiration and final results of its cash tender offer for its 2.50% Convertible Senior Notes due 2023. The offer was highly successful, with approximately 95.6% of the outstanding principal amount, or $282.3 million, being tendered. Thermo Fisher Scientific expects to pay approximately $586.6 million to settle this transaction, indicating a strong buyback of these convertible notes.
Key Highlights
- 1Thermo Fisher Scientific completed the redemption of all outstanding 6.75% Senior Subordinated Notes due 2014.
- 2The total cost for redeeming the Senior Subordinated Notes was approximately $317.0 million.
- 3The company's cash tender offer for its 2.50% Convertible Senior Notes due 2023 expired on December 17, 2009.
- 4A substantial 95.6% ($282.3 million in principal) of the Convertible Notes were validly tendered and accepted for purchase.
- 5The aggregate payment for the tendered Convertible Notes is expected to be approximately $586.6 million, including accrued interest.
- 6These actions indicate active debt management and potentially a shift in the company's capital structure.